SCHEMBL5698704

SCHEMBL5698704

Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)n1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.78
RAB9A P51151 1/20 0.78
ALOX5 P09917 1/20 0.65
ALDH1A1 P00352 3/20 0.63
HPGD P15428 3/20 0.63
PTGS2 P35354 2/20 0.63
MALT1 Q9UDY8 2/20 0.59
GAA P10253 3/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
RECQL P46063 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
FFAR4 Q5NUL3 1/20 0.55
PPP1CA P62136 1/20 0.55
POLB P06746 1/20 0.54
RPA1 P27694 1/20 0.54
MEN1 O00255 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10645870 0.88 NPC1 (1.00) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL10194259 0.87 NPC1 (0.83) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL12361461 0.85 NPC1 (0.93) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL17592920 0.84 PTGS2 (0.62) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL6266602 0.84 PTGS2 (0.62) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL11382119 0.84 NPC1 (0.78) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL12759783 0.84 NPC1 (0.78) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL27907544 0.81 SLC16A3 (0.59) NPC1RAB9APTGS2MALT1SMN1; SMN2
SCHEMBL11377231 0.81 NPC1 (0.73) NPC1RAB9AALOX5ALDH1A1HPGD
SCHEMBL27890742 0.81 MALT1 (0.56) NPC1RAB9AALDH1A1PTGS2MALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed